PRO-ONKO-selection of patient-reported outcome assessments for the clinical use in cancer patients-a mixed-method multicenter cross-sectional exploratory study

被引:9
作者
Schmidt, Heike [1 ]
Merkel, Daniela [1 ]
Koehler, Michael [2 ]
Flechtner, Hans-Henning [3 ]
Sigle, Joerg [4 ,5 ]
Klinge, Bernd [6 ]
Jordan, Karin [7 ]
Vordermark, Dirk [8 ]
Landenberger, Margarete [1 ]
Jahn, Patrick [1 ,9 ]
机构
[1] Univ Halle Wittenberg, Inst Hlth & Nursing Sci, Fac Med, D-06108 Halle, Saale, Germany
[2] Otto Von Guericke Univ, Univ Hosp, Dept Hematol & Oncol, Magdeburg, Germany
[3] Otto Von Guericke Univ, Dept Child & Adolescent Psychiat, Magdeburg, Germany
[4] Sci IT Consulting, Bettingen, Switzerland
[5] Reha Chrischona, Bettingen, Switzerland
[6] Helios Klin, Dept Surg, Sangerhausen, Germany
[7] Univ Halle Wittenberg, Univ Hosp Halle, Dept Internal Med Hematol & Oncol 4, Halle, Saale, Germany
[8] Univ Halle Wittenberg, Univ Hosp Halle, Dept Radiat Oncol, Halle, Saale, Germany
[9] Univ Halle Wittenberg, Univ Hosp Halle, Nursing Res Unit, Halle, Saale, Germany
关键词
Patient-reported outcomes; Cancer; Quality of life; Screening; Monitoring; Supportive therapy; QUALITY-OF-LIFE; CARE; EXPERIENCES; VALIDATION; COLLECTION; SYMPTOMS; DISTRESS; DESIGN; SYSTEM;
D O I
10.1007/s00520-015-3055-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Cancer patients frequently suffer from multiple symptoms often impairing functional status and health-related quality of life (HRQOL). A comprehensive assessment including patient-reported outcomes (PROs) is recommended to enable individualized supportive care. However, PRO assessments are still not part of routine clinical practice. Therefore, this project aimed to compile an item pool from validated assessment instruments to facilitate the use of PROs for clinical decision-making in oncology clinics. Methods This qualitative dominant mixed-method cross-sectional exploratory study was carried out in four centers and comprised two stages. Stage I: Six interdisciplinary focus groups were conducted to choose questionnaires meeting particular clinical requirements. Stage II: Adult patients with heterogeneous cancer diagnoses, receiving in- or out-patient treatment were asked to participate and complete the chosen questionnaires (participation 71/74). Resulting PROs were compared with clinical records. Health care professionals (HCPs) and patients rated the usefulness for routine clinical practice. Results The European Organisation of Research and Treatment of Cancer (EORTC) QLQ-C30 and Distress Thermometer were chosen for screening and M.D. Anderson Symptom Inventory (MDASI) and EORTC single items for monitoring. Comparison of n = 88 PRO assessments with clinical records showed consistent documentation of side effects like fever and emesis. Symptoms like fatigue, sadness, or sleep disturbance were not documented regularly in the medical records but captured by PRO assessments. Patients and HCPs judged the chosen questionnaires and electronic data collection as useful. Conclusions Future studies should examine how PROs can complement or substitute routine documentation in order to achieve standardized assessment and documentation during the treatment process in different settings and examine possible benefits for patients.
引用
收藏
页码:2503 / 2512
页数:10
相关论文
共 44 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] [Anonymous], SUPPORT CARE CANC
  • [3] [Anonymous], CANC REL FAT
  • [4] Implementing patient-reported outcome measures in palliative care clinical practice: A systematic review of facilitators and barriers
    Antunes, Barbara
    Harding, Richard
    Higginson, Irene J.
    [J]. PALLIATIVE MEDICINE, 2014, 28 (02) : 158 - 175
  • [5] Supporting Clinical Practice Decisions With Real-Time Patient-Reported Outcomes
    Basch, Ethan
    Abernethy, Amy P.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (08) : 954 - 956
  • [6] The Missing Voice of Patients in Drug-Safety Reporting
    Basch, Ethan
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (10) : 865 - 869
  • [7] Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system
    Bonomi, AE
    Cella, DF
    Hahn, EA
    Bjordal, K
    SpernerUnterweger, B
    Gangeri, L
    Bergman, B
    WillemsGroot, J
    Hanquet, P
    Zittoun, R
    [J]. QUALITY OF LIFE RESEARCH, 1996, 5 (03) : 309 - 320
  • [8] The experiences of professionals with using information from patient-reported outcome measures to improve the quality of healthcare: a systematic review of qualitative research
    Boyce, Maria B.
    Browne, John P.
    Greenhalgh, Joanne
    [J]. BMJ QUALITY & SAFETY, 2014, 23 (06) : 508 - 518
  • [9] Brundage MD, 2015, QUAL LIFE RES
  • [10] A systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting
    Chen, Jack
    Ou, Lixin
    Hollis, Stephanie J.
    [J]. BMC HEALTH SERVICES RESEARCH, 2013, 13